test

Sam Huang

@Checkpoint Capital L.p.

Latest period2024 - Q3ReportedManaged Assets$201.574MTotal holdings16
Assets growth rate21.52%Assets growth rate (2-Q avg)16.19%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Checkpoint Capital L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 16 positions.

Assets under management

The assets under management (AUM) of Checkpoint Capital L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 201.574M in assets, with a quarterly growth rate of 21.52% and a 2-quarter average growth rate of 16.19%. The portfolio is managed by Sam Huang, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ARGXArgenx Se
Recent Activity
Increased 12.6%
24.88%
$50.142M
92,500 shares@ $542.08 avg price
RYTMRhythm Pharmaceuticals Inc
Recent Activity
Decreased -28.05%
17.25%
$34.755M
663,381 shares@ $52.4 avg price
PHATPhathom Pharmaceuticals Inc
Recent Activity
Increased 71.93%
13.5%
$27.198M
1.504M shares@ $18.09 avg price
CYTKCytokinetics Inc
Recent Activity
Increased 145.7%
12.23%
$24.648M
466,813 shares@ $52.8 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Decreased -27.9%
9.35%
$18.84M
209,632 shares@ $89.88 avg price
AVDLAvadel Pharmaceuticals Plc
Recent Activity
Decreased -3.35%
7.16%
$14.427M
1.1M shares@ $13.12 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
Decreased -32.39%
5.36%
$10.8M
240,000 shares@ $45.0 avg price
PLRXPliant Therapeutics Inc
Recent Activity
Increased 63.66%
2.12%
$4.26M
380,000 shares@ $11.21 avg price
TCRXTscan Therapeutics Inc
Recent Activity
New Position
2.04%
$4.11M
825,341 shares@ $4.98 avg price
ATYRAtyr Pharma Inc
Recent Activity
Decreased -10.78%
1.52%
$3.056M
1.736M shares@ $1.77 avg price